![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipel... uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Show more
~ Designation based on 24-month interim Phase I/II clinical data for AMT-130 announced in December 2023 ~ ~ AMT-130 is the first therapeutic candidate to receive RMAT Designation for Huntingtonβs...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.69 | -13.1178707224 | 5.26 | 5.34 | 4.515 | 519175 | 4.79294073 | CS |
4 | -0.47 | -9.3253968254 | 5.04 | 5.62 | 4.515 | 635327 | 5.09125417 | CS |
12 | -0.77 | -14.4194756554 | 5.34 | 5.62 | 4.25 | 602678 | 4.94730258 | CS |
26 | -2.19 | -32.3964497041 | 6.76 | 7.12 | 4.25 | 869058 | 5.51876694 | CS |
52 | -14.89 | -76.5159301131 | 19.46 | 19.63 | 4.25 | 1056454 | 7.07940047 | CS |
156 | -28.51 | -86.1850060459 | 33.08 | 38.8 | 4.25 | 752834 | 15.14844919 | CS |
260 | -74.14 | -94.1938762546 | 78.71 | 82.49 | 4.25 | 649799 | 25.63848808 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions